Moser H - Search Results

1

Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Ramanathan-Girish S, McColm J, Clements JM, Taupin P, Barrowcliffe S, Hevizi J, Safrin S, Moore C, Patou G, Moser H, Gadd A, Hoch U, Jiang V, Lofland D, Johnson KW. Ramanathan-Girish S, et al. Among authors: moser h. Antimicrob Agents Chemother. 2004 Dec;48(12):4835-42. doi: 10.1128/AAC.48.12.4835-4842.2004. Antimicrob Agents Chemother. 2004. PMID: 15561864 Free PMC article. Clinical Trial.

2

Pharmacology of novel heteroaromatic polycycle antibacterials.

Gross M, Bürli R, Jones P, Garcia M, Batiste B, Kaizerman J, Moser H, Jiang V, Hoch U, Duan JX, Tanaka R, Johnson KW. Gross M, et al. Among authors: moser h. Antimicrob Agents Chemother. 2003 Nov;47(11):3448-57. doi: 10.1128/AAC.47.11.3448-3457.2003. Antimicrob Agents Chemother. 2003. PMID: 14576101 Free PMC article.

3

In vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound.

Ge Y, Difuntorum S, Touami S, Critchley I, Bürli R, Jiang V, Drazan K, Moser H. Ge Y, et al. Among authors: moser h. Antimicrob Agents Chemother. 2002 Oct;46(10):3168-74. doi: 10.1128/AAC.46.10.3168-3174.2002. Antimicrob Agents Chemother. 2002. PMID: 12234840 Free PMC article.

4

PDF inhibitors: an emerging class of antibacterial drugs.

Johnson KW, Lofland D, Moser HE. Johnson KW, et al. Among authors: moser he. Curr Drug Targets Infect Disord. 2005 Mar;5(1):39-52. doi: 10.2174/1568005053174618. Curr Drug Targets Infect Disord. 2005. PMID: 15777197 Review.

5

Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.

Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D. Hu X, et al. J Med Chem. 2004 Sep 23;47(20):4941-9. doi: 10.1021/jm049592c. J Med Chem. 2004. PMID: 15369398

6

DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.

Hu W, Bürli RW, Kaizerman JA, Johnson KW, Gross MI, Iwamoto M, Jones P, Lofland D, Difuntorum S, Chen H, Bozdogan B, Appelbaum PC, Moser HE. Hu W, et al. Among authors: moser he. J Med Chem. 2004 Aug 26;47(18):4352-5. doi: 10.1021/jm049712g. J Med Chem. 2004. PMID: 15317448

7

DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.

Kaizerman JA, Gross MI, Ge Y, White S, Hu W, Duan JX, Baird EE, Johnson KW, Tanaka RD, Moser HE, Bürli RW. Kaizerman JA, et al. J Med Chem. 2003 Aug 28;46(18):3914-29. doi: 10.1021/jm030097a. J Med Chem. 2003. PMID: 12930152

8

DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.

Bürli RW, Kaizerman JA, Duan JX, Jones P, Johnson KW, Iwamoto M, Truong K, Hu W, Stanton T, Chen A, Touami S, Gross M, Jiang V, Ge Y, Moser HE. Bürli RW, et al. Bioorg Med Chem Lett. 2004 May 3;14(9):2067-72. doi: 10.1016/j.bmcl.2004.02.047. Bioorg Med Chem Lett. 2004. PMID: 15080980

9

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.

Bürli RW, McMinn D, Kaizerman JA, Hu W, Ge Y, Pack Q, Jiang V, Gross M, Garcia M, Tanaka R, Moser HE. Bürli RW, et al. Bioorg Med Chem Lett. 2004 Mar 8;14(5):1253-7. doi: 10.1016/j.bmcl.2003.12.042. Bioorg Med Chem Lett. 2004. PMID: 14980676

10

Synthesis and spectrum of the neoglycoside ACHN-490.

Aggen JB, Armstrong ES, Goldblum AA, Dozzo P, Linsell MS, Gliedt MJ, Hildebrandt DJ, Feeney LA, Kubo A, Matias RD, Lopez S, Gomez M, Wlasichuk KB, Diokno R, Miller GH, Moser HE. Aggen JB, et al. Among authors: moser he. Antimicrob Agents Chemother. 2010 Nov;54(11):4636-42. doi: 10.1128/AAC.00572-10. Epub 2010 Aug 30. Antimicrob Agents Chemother. 2010. PMID: 20805391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

940 results

Search Page